New Key Statistics Module, Z-Score and F-Score
OTCPK:MBGPF Key Ratios
| Market Cap $ M | 51.69 |
| Enterprise Value $ M | 21.23 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.58 |
| Price/Sales | 78.52 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.09 |
| Beneish M-Score | 17.67 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.28 |
| EV-to-EBITDA | -8.78 |
| PEG | -- |
| Shares Outstanding M | 46.69 |
| Net Margin (%) | -461.64 |
| Operating Margin % | -595.33 |
| Pre-tax Margin (%) | -554.41 |
| Quick Ratio | 12.32 |
| Current Ratio | 12.49 |
| ROA % (ttm) | -3.33 |
| ROE % (ttm) | -3.46 |
| ROIC % (ttm) | -4.20 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.53 |
MBGPF Number of Guru Trades
MBGPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MBGPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MBGPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Moberg Pharma AB Insider Transactions
No Available Data
News about OTCPK:MBGPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers